Legend Biotech Updates Presentation for J.P. Morgan Conference
Ticker: LEGN · Form: 6-K · Filed: Jan 14, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, conference
TL;DR
Legend Biotech dropping updated corporate deck at JPM conference Jan 14.
AI Summary
Legend Biotech Corporation announced on January 14, 2025, that it will make an updated corporate presentation available on its website. This presentation will be shared at the 43rd Annual J.P. Morgan Healthcare Conference.
Why It Matters
This update signals Legend Biotech's ongoing engagement with key industry events and investors, providing insights into their latest corporate developments.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain significant financial or operational news that would inherently increase risk.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- J.P. Morgan Healthcare Conference (event) — Conference where presentation is shared
- January 14, 2025 (date) — Date of announcement and presentation
FAQ
What is the purpose of the updated corporate presentation?
The purpose is to provide an update on Legend Biotech's corporate information at the 43rd Annual J.P. Morgan Healthcare Conference.
When will the updated corporate presentation be available?
The updated corporate presentation will be made available on January 14, 2025.
Where can investors access the updated corporate presentation?
Investors can access the updated corporate presentation on Legend Biotech's website.
Which conference is Legend Biotech participating in?
Legend Biotech is participating in the 43rd Annual J.P. Morgan Healthcare Conference.
What is the filing type and date?
This is a Form 6-K filed on January 14, 2025.
Filing Stats: 303 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-01-14 16:01:42
Filing Documents
- f6k_011425.htm (6-K) — 11KB
- exh_991.htm (EX-99.1) — 38KB
- exh991_01.jpg (GRAPHIC) — 97KB
- exh991_02.jpg (GRAPHIC) — 298KB
- exh991_03.jpg (GRAPHIC) — 162KB
- exh991_04.jpg (GRAPHIC) — 142KB
- exh991_05.jpg (GRAPHIC) — 164KB
- exh991_06.jpg (GRAPHIC) — 190KB
- exh991_07.jpg (GRAPHIC) — 180KB
- exh991_08.jpg (GRAPHIC) — 109KB
- exh991_09.jpg (GRAPHIC) — 150KB
- exh991_10.jpg (GRAPHIC) — 130KB
- exh991_11.jpg (GRAPHIC) — 177KB
- exh991_12.jpg (GRAPHIC) — 170KB
- exh991_13.jpg (GRAPHIC) — 186KB
- exh991_14.jpg (GRAPHIC) — 220KB
- exh991_15.jpg (GRAPHIC) — 126KB
- exh991_16.jpg (GRAPHIC) — 166KB
- exh991_17.jpg (GRAPHIC) — 108KB
- exh991_18.jpg (GRAPHIC) — 161KB
- exh991_19.jpg (GRAPHIC) — 174KB
- exh991_20.jpg (GRAPHIC) — 166KB
- exh991_21.jpg (GRAPHIC) — 186KB
- exh991_22.jpg (GRAPHIC) — 193KB
- exh991_23.jpg (GRAPHIC) — 170KB
- exh991_24.jpg (GRAPHIC) — 174KB
- exh991_25.jpg (GRAPHIC) — 67KB
- exh991_26.jpg (GRAPHIC) — 84KB
- exh991_27.jpg (GRAPHIC) — 88KB
- exh991_28.jpg (GRAPHIC) — 107KB
- exh991_29.jpg (GRAPHIC) — 176KB
- 0001171843-25-000244.txt ( ) — 6270KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. LEGEND BIOTECH CORPORATION Date: January 14, 2025 By: /s/ Ying Huang Name: Ying Huang, Ph.D. Title: Chief Executive Officer